Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Klotho Gene Therapy
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Preclinical
Sponsor : Japan’s Okinawa Research Center
Deal Size : Undisclosed
Deal Type : Partnership
ANEW MEDICAL Partners with Okinawa Research Center to Study Klotho Gene
Details : The collaboration aims to focus on the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 27, 2024
Lead Product(s) : Klotho Gene Therapy
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Preclinical
Sponsor : Japan’s Okinawa Research Center
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Alpha Klotho-based Gene Therapy
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Redwoods Acquisition Corp.
Deal Size : Undisclosed
Deal Type : Merger
Anew Medical, Inc. Enters Into Definitive Merger Agreement with Redwoods Acquisition Corp.
Details : ANEW intends to use the proceeds from the transaction to progress its lead gene therapy programs including, Alpha Klotho-based gene therapy being developed for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
May 30, 2023
Lead Product(s) : Alpha Klotho-based Gene Therapy
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Redwoods Acquisition Corp.
Deal Size : Undisclosed
Deal Type : Merger
LOOKING FOR A SUPPLIER?